Nuformix (LON:NFX) Shares Up 5.1% – What’s Next?

Nuformix plc (LON:NFX) shot up 5.1% during trading on Thursday . The company traded as high as GBX 0.31 and last traded at GBX 0.31. 10,830,912 shares traded hands during trading, a decline of 43% from the average session volume of 18,889,604 shares. The stock had previously closed at GBX 0.30.

Nuformix Trading Up 3.1%

The firm has a 50-day moving average price of GBX 0.28 and a 200 day moving average price of GBX 0.21. The company has a market cap of £6.41 million, a price-to-earnings ratio of -0.77 and a beta of 1.22.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications.